12/22
07:03 pm
ilmn
Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]
Low
Report
Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]
12/22
07:00 pm
ilmn
Macrogen Consortium win tender for National Bio Big Data Project
Low
Report
Macrogen Consortium win tender for National Bio Big Data Project
12/17
09:13 am
ilmn
Ovation.io and Illumina Collaborate to Advance Genomic Data Research
Low
Report
Ovation.io and Illumina Collaborate to Advance Genomic Data Research
12/17
07:47 am
ilmn
Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]
Low
Report
Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]
12/13
09:03 pm
ilmn
MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]
Low
Report
MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]
12/11
08:08 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock, down previously from $190.00.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock, down previously from $190.00.
12/10
09:15 am
ilmn
The World Market for Blood Ketone Meters, Forecast to 2029: Discover Regional Business Trends for Human & Veterinary Applications in Hospitals, Diagnostic Centers, Homecare Settings and More [Yahoo! Finance]
Low
Report
The World Market for Blood Ketone Meters, Forecast to 2029: Discover Regional Business Trends for Human & Veterinary Applications in Hospitals, Diagnostic Centers, Homecare Settings and More [Yahoo! Finance]
12/7
09:03 am
ilmn
Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27% CAGR | Report by S&S Insider [Yahoo! Finance]
Medium
Report
Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27% CAGR | Report by S&S Insider [Yahoo! Finance]
12/5
11:34 am
ilmn
Anaerobic Digestion Systems Market to Reach $32.1 Billion by 2031 - Exclusive Report by Meticulous Research® [Yahoo! Finance]
Low
Report
Anaerobic Digestion Systems Market to Reach $32.1 Billion by 2031 - Exclusive Report by Meticulous Research® [Yahoo! Finance]
12/5
06:05 am
ilmn
Cell-Free DNA Mutation Diagnostics Market to Surge to US$ 81,584.2 Million by 2034, Growing at a CAGR of 24.9% | Fact.MR Report [Yahoo! Finance]
Low
Report
Cell-Free DNA Mutation Diagnostics Market to Surge to US$ 81,584.2 Million by 2034, Growing at a CAGR of 24.9% | Fact.MR Report [Yahoo! Finance]
12/4
04:07 pm
ilmn
Illumina To Webcast Upcoming Investor Conference
Low
Report
Illumina To Webcast Upcoming Investor Conference
12/4
01:28 pm
ilmn
Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
12/4
03:36 am
ilmn
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications [Yahoo! Finance]
Low
Report
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications [Yahoo! Finance]
12/4
03:30 am
ilmn
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
Low
Report
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
12/4
03:30 am
ilmn
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
Low
Report
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
11/19
03:40 pm
ilmn
Preimplantation Genetic Testing Market Set to Reach $1.2 Billion by 2031, Driven by Advances in Genetic Screening and Growing IVF Demand: Market Research Intellect [Yahoo! Finance]
Low
Report
Preimplantation Genetic Testing Market Set to Reach $1.2 Billion by 2031, Driven by Advances in Genetic Screening and Growing IVF Demand: Market Research Intellect [Yahoo! Finance]
11/19
09:25 am
ilmn
Illumina announces expansion of TruSight Oncology portfolio [Yahoo! Finance]
Low
Report
Illumina announces expansion of TruSight Oncology portfolio [Yahoo! Finance]
11/19
09:15 am
ilmn
Illumina announces expansion of TruSight Oncology portfolio
Medium
Report
Illumina announces expansion of TruSight Oncology portfolio
11/18
01:01 pm
ilmn
INITIATE Ventures Closes $45 Million to Fund and Co-create Companies at the Intersection of Healthcare, Life Sciences, and Tech
Low
Report
INITIATE Ventures Closes $45 Million to Fund and Co-create Companies at the Intersection of Healthcare, Life Sciences, and Tech
11/12
08:33 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Stephens from $170.00 to $184.00. They now have an "overweight" rating on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Stephens from $170.00 to $184.00. They now have an "overweight" rating on the stock.
11/12
08:33 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $156.00 price target on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $156.00 price target on the stock.
11/12
12:17 am
ilmn
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics [Yahoo! Finance]
Low
Report
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics [Yahoo! Finance]
11/11
11:49 am
ilmn
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
11/11
08:09 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Piper Sandler from $195.00 to $185.00. They now have an "overweight" rating on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Piper Sandler from $195.00 to $185.00. They now have an "overweight" rating on the stock.
11/11
04:22 am
ilmn
Whole Genome and Exome Sequencing Market Research 2024-2033: Driving Down Costs, Enhancing Patient Outcomes, and Influencing Global Healthcare Policies [Yahoo! Finance]
Low
Report
Whole Genome and Exome Sequencing Market Research 2024-2033: Driving Down Costs, Enhancing Patient Outcomes, and Influencing Global Healthcare Policies [Yahoo! Finance]